Alternative Treatment Option for Multiple Myeloma

Submitted by admin5 on Fri, 06/16/2017 - 14:25

According to recent research presented at ASCO, adding which targeting agent to standard of care carfilzomib, lenalidomide, and dexamethasone is a safe and efficacious alternative to ASCT for patients with multiple myeloma?


A. Daratumumab

B. Elotuzumab 

C. Pembrolizumab

D. Nivolumab


See the answer here.